Medication info
Alzmetin Tablet (Memantine Hydrochloride)

Alzmetin Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Hungkuk Hyutex Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201600877 · Approved 2016.02.16 · Insurance code 649102970

Summary

Main use
Treatment of moderate~severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver is available to regularly confirm that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this drug and the patient’s tolerability of treatment should be reassessed regularly. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7): Administer 5mg once daily for 7 days. Week 2 (days 8-14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15-21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Hungkuk Hyutex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate~severe Alzheimer's disease

View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only if a caregiver is available to regularly confirm that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this drug and the patient’s tolerability of treatment should be reassessed regularly. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7): Administer 5mg once daily for 7 days. Week 2 (days 8-14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15-21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medication should not be used by patients who are allergic to its components, patients with severely impaired liver function, and patients with significantly reduced kidney function. Additionally, this medication contains lactose, and patients with genetic disorders that prevent lactose digestion should not take it. Patients with epilepsy or a history of seizures, as well as those at high risk for seizures, must use this medication with caution. If taken with certain other medications, side effects may increase or persist, so it should not be used with NMDA antagonist class medications. Patients with dietary changes that affect urine acidity or specific diseases should be cautious, and the safety of this medication has not been adequately confirmed in patients with heart disease or uncontrolled hypertension. Taking this medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, and in rare cases, hallucinations or psychotic symptoms have been reported. This medication may interact with other drugs, so if taking any other medications, they must inform their healthcare provider, especially when combined with anticoagulants or certain gastrointestinal medications. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and breastfeeding should be discontinued while taking it. The safety and efficacy of this medication have not been adequately confirmed in children and adolescents under the age of 18. In case of overdose, serious symptoms such as coma, hallucinations, and seizures may occur, so immediate emergency treatment is required, and since there is no specific antidote, symptomatic treatment is necessary. This medication may affect the central nervous system, so caution is required when driving or operating machinery. Finally, this medication should be kept out of the reach of children, and transferring it to another container is important for safety and maintaining quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity
  • confusion
  • hallucination
  • psychotic reactions
Show 24 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • convulsions
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius, and it is advisable to avoid excessively hot or cold places.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.